National Heart Failure Registry
Launched by NATIONAL MEDICAL RESEARCH CENTER FOR CARDIOLOGY, MINISTRY OF HEALTH OF RUSSIAN FEDERATION · Nov 8, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The National Heart Failure Registry is a study looking at patients with chronic heart failure (CHF) in different regions of Russia. This trial is designed to collect information about how patients are doing over time without changing their treatment. It will help researchers understand more about this condition by observing patients and their experiences.
If you or a loved one has been diagnosed with any stage or class of chronic heart failure and are between the ages of 65 and 74, you may be eligible to participate. The study is currently recruiting participants, and it does not require any specific treatment changes. However, individuals whose medical records cannot be accessed for analysis will not be included. Participants can expect to share their health information, which will contribute to a better understanding of chronic heart failure in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Any stage and/or any class of CHF
- Exclusion Criteria:
- • Subjects whose source records cant be obtained for the analysis
About National Medical Research Center For Cardiology, Ministry Of Health Of Russian Federation
The National Medical Research Center for Cardiology, under the auspices of the Ministry of Health of the Russian Federation, is a leading institution dedicated to advancing cardiovascular health through innovative research and clinical trials. With a commitment to improving patient outcomes, the center focuses on the prevention, diagnosis, and treatment of cardiovascular diseases, leveraging cutting-edge medical technologies and methodologies. By fostering collaboration among healthcare professionals, researchers, and policymakers, the center aims to contribute significantly to the global understanding of cardiology and enhance the quality of care provided to patients in Russia and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Moscow, , Russian Federation
Patients applied
Trial Officials
Sergey A Boytsov, Prof.
Study Chair
E.I.Chazov Cardiology Center
Zoya N Blankova, MD, PhD
Study Director
E.I.Chazov Cardiology Center
Fail' T Ageev, Prof.
Principal Investigator
E.I.Chazov Cardiology Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported